Improving drug development with a vast map of the immune system
Immunai, founded by two researchers from MIT, is helping pharmaceutical companies identify the patients that stand to benefit most from new treatments.
Source: mit.edu
Stay updated with breaking news from Annotated Multiomic Immune Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunai, founded by two researchers from MIT, is helping pharmaceutical companies identify the patients that stand to benefit most from new treatments.